A Phase IIIb Multi-Center, Double-Blind, Placebo-Controlled, Randomized Trial to Examine the Corticosteroid-Sparing Effect of Certolizaumab Pegol in Patients with Moderate to Severe Crohn's Disease

  • De Villiers, Willem (PI)
  • Winter, Trevor (Former PI)

Grants and Contracts Details

StatusFinished
Effective start/end date8/1/077/31/09